powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1487013512
Ayman Daoud
Neurology
Chesterfield,
MO
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
QUALITY · MIPS · 2024
Final MIPS score
92.7
Quality
82.3
Cost
0.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.75%
APM Entity
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$3K
Payment records
172
By payment type
Food and Beverage
$3K
Education
$76
Top paying entities
Food and Beverage
$3K
Education
$76
PRESCRIBING · PART D · 2024
Total Rx claims
2,951
Beneficiaries
—
Total drug cost
$208K
Distinct drugs
42
Brand share
30.1%
Top prescribed drugs
Carbidopa/Levodopa
466 claims
Gabapentin
327 claims
Memantine Hcl
282 claims
Pregabalin
198 claims
Nortriptyline Hcl
141 claims
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
958
Unique beneficiaries
—
Total services
1,220
Distinct HCPCS
17
Medicare payment
$100K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 312 Neurology providers in MO — top quintile (cohort median 552).